𝔖 Bobbio Scriptorium
✦   LIBER   ✦

One-year results of the INSPIRE trial with the novel MGuard stent: Serial analysis with QCA and IVUS

✍ Scribed by J. Ribamar Costa Jr.; Alexandre Abizaid; Fausto Feres; Ricardo Costa; Rodolfo Staico; Dimytri Siqueira; Marinella Centemero; Luiz Fernando Tanajura; Amanda Sousa; J. Eduardo Sousa

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
135 KB
Volume
78
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of the INSPIRE trial
Preliminary results of the INSPIRE trial with the novel MGuard™ stent system containing a protection net to prevent distal embolization
✍ Felipe Maia; J. Ribamar Costa Jr; Alexandre Abizaid; Fausto Feres; Ricardo Costa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract Objective: To assess the efficacy of the MGuard^TM^ stent combining a polymer‐mesh sleeve attached to the external surface of a bare‐metal stent in preventing distal embolization during percutaneous coronary intervention (PCI). Background: Distal embolization of thrombus/platelet agregg

Evaluation of the effects of everolimus-
Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial
✍ Robert Applegate; James Hermiller; Jerome Williams; Paul Gordon; Julie Doostzade 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## Abstract Objective: To evaluate whether an everolimus‐eluting stent (EES) with thinner stent struts and polymer results in less periprocedural myonecrosis and adverse outcomes. Background: Higher periprocedural myocardial infarction (MI) rates have been reported with the TAXUS® EXPRESS^2^ paclit

Randomized evaluation of two drug-elutin
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-Year results of the PAINT trial
✍ Pedro A. Lemos; Bruno Moulin; Marco A. Perin; Ludmilla A.R.R. Oliveira; J. Airto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 1 views

## Abstract Objectives: We tested two novel drug‐eluting stents (DES), covered with a biodegradable‐polymer carrier and releasing paclitaxel or sirolimus, which were compared against a bare metal stent (primary objective). The DES differed by the drug, but were identical otherwise, allowing to comp

Economic outcomes of percutaneous corona
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial
✍ David J. Cohen; Tara A. Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization for patients with three‐vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long‐term costs with bypass surgery